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Mutations affecting the germline can result in infertility or the generation of germ cell
tumors (GCT), highlighting the need to identify and characterize the genes controlling
germ cell development. The RNA-binding protein and E3 ubiquitin ligase TRIM71 is
essential for embryogenesis, and its expression has been reported in GCT and adult
mouse testes. To investigate the role of TRIM71 in mammalian germ cell embryonic
development, we generated a germline-specific conditional Trim71 knockout mouse
(cKO) using the early primordial germ cell (PGC) marker Nanos3 as a Cre-recombinase
driver. cKO mice are infertile, with male mice displaying a Sertoli cell-only (SCO)
phenotype which in humans is defined as a specific subtype of non-obstructive
azoospermia characterized by the absence of germ cells in the seminiferous tubules.
Infertility in male Trim71 cKO mice originates during embryogenesis, as the SCO
phenotype was already apparent in neonatal mice. The in vitro differentiation of mouse
embryonic stem cells (ESCs) into PGC-like cells (PGCLCs) revealed reduced numbers
of PGCLCs in Trim71-deficient cells. Furthermore, TCam-2 cells, a human GCT-derived
seminoma cell line which was used as an in vitro model for PGCs, showed proliferation
defects upon TRIM71 knockdown. Additionally, in vitro growth competition assays, as
well as proliferation assays with wild type and CRISPR/Cas9-generated TRIM71 mutant
NCCIT cells showed that TRIM71 also promotes proliferation in this malignant GCT-
derived non-seminoma cell line. Importantly, the PGC-specific markers BLIMP1 and
NANOS3 were consistently downregulated in Trim71 KO PGCLCs, TRIM71 knockdown
TCam-2 cells and TRIM71 mutant NCCIT cells. These data collectively support a role for
TRIM71 in PGC development. Last, via exome sequencing analysis, we identified several
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TRIM71 variants in a cohort of infertile men, including a loss-of-function variant in
a patient with an SCO phenotype. Altogether, our work reveals for the first time an
association of TRIM71 deficiency with human male infertility, and uncovers further
developmental roles for TRIM71 in the germline during mouse embryogenesis.
Keywords: TRIM71/LIN-41, infertility/sterility, azoospermia, Sertoli cell-only (SCO) phenotype, primordial germ
cells (PGCs), mammalian gonad development, germ cell tumors (GCT), Haystack
INTRODUCTION
Despite the recent insights into the regulation of mammalian
germ cell development and the advances in assisted reproductive
technologies, infertility remains a common problem in modern
society affecting ∼15% of couples in industrialized countries
(Agarwal et al., 2015). Genetic defects during germ cell
development can drive infertility and increase susceptibility to
germ cell tumors (GCT) (Raman et al., 2005; Looijenga et al.,
2010; Zorrilla and Yatsenko, 2013).
Primordial germ cells (PGCs) are the first established germ
cell population during embryonic development. In mice, PGC
specification is initiated in the post-implantation epiblast at
embryonic day (E) 6.25 in response to BMP4 signaling from the
extra-embryonic ectoderm (Lawson et al., 1999). BMP4 activates
the expression of Prdm14 (Yamaji et al., 2008) and Prdm1/Blimp1
(Ohinata et al., 2005). BLIMP1 then activates the expression of
Tfap2c (Kurimoto et al., 2008), and together BLIMP1, TFAP2C
and PRDM14 establish the transcriptional program required for
PGC specification (Wang and Cao, 2016) which is completed at
E7.5. At this time point, about 40 cells in the proximal epiblast
express early PGC-specific markers such as Nanos3 (Ginsburg
et al., 1990; Tsuda et al., 2003). PGCs then migrate to the genital
ridges (developing gonads) while slowly proliferating (Tam and
Snow, 1981; Anderson et al., 2000). At E10.5, around 1000
PGCs colonize the genital ridges, upregulate late PGC markers
such as Ddx4/Vasa (Fujiwara et al., 1994; Tanaka et al., 2000)
and Gcna1 (Enders and May, 1994), and undergo significant
proliferation before initiating sex determination (Bowles and
Koopman, 2010; Ewen and Koopman, 2010). Importantly, PGCs
that fail to reach the genital ridges or to further differentiate into
gametes are the origin of GCT, which often affect children and
young adults (Raman et al., 2005; Looijenga et al., 2010; Zorrilla
and Yatsenko, 2013; Pierce et al., 2018). Therefore, unraveling
the processes controlling germline development will not only
contribute to our understanding of infertility, but may also offer
unique opportunities for the treatment of GCT.
Tripartite Motif Containing 71 (TRIM71) belongs to the
TRIM-NHL protein family. TRIM71’s versatile domain structural
organization (Ecsedi and Grosshans, 2013) enables its role as
an E3 ubiquitin ligase (Chen et al., 2012; Nguyen et al., 2017;
Ren et al., 2018; Hu et al., 2019) and an mRNA-binding
protein (Chang et al., 2012; Loedige et al., 2013; Worringer
et al., 2014; Mitschka et al., 2015; Torres-Fernández et al.,
2019). TRIM71 function is essential for embryogenesis and its
expression is mostly restricted to undifferentiated cells during
early proliferative developmental stages, being downregulated in
the course of differentiation (Schulman et al., 2005, 2008; Rybak
et al., 2009; Cuevas et al., 2015). However, a postnatal Trim71
expression has also been observed in adult mouse testes (Rybak
et al., 2009; Du et al., 2020) as well as in several GCT-derived cell
lines (Rybak et al., 2009; Chang et al., 2012; Torres-Fernández
et al., 2019), and a recent study has reported a postnatal
function for TRIM71 in adult mouse spermatogenesis (Du et al.,
2020). Furthermore, RNA sequencing of Trim71-deficient mouse
embryonic stem cells (ESCs) revealed a decreased expression of
genes associated with reproductive processes (Mitschka et al.,
2015), suggesting an early developmental role for TRIM71
in the germline.
To elucidate the role of TRIM71 in mammalian embryonic
germ cell development, we generated a mouse model with
an early germline-specific depletion of Trim71 driven by the
Nanos3 promoter (Nanos3-Cre). Additionally, we employed an
in vitro approach for the differentiation of wild type and
Trim71-deficient murine ESCs into PGC-like cells (PGCLCs) in
order to study the role of TRIM71 during PGC specification.
Furthermore, we used the human GCT-derived seminoma cell
line TCam-2 as a surrogate in vitro model of PGCs and evaluated
cell proliferation upon TRIM71 knockdown. Additionally, we
used the human GCT-derived non-seminoma cell line NCCIT
to generate TRIM71 mutations via CRISPR/Cas9 in order to
investigate the role of TRIM71 in the proliferation of pluripotent
embryonal carcinoma cells. Last, we used exome sequencing data
from infertile men and developed a novel software tool named
Haystack to search for novel genetic causes of infertility. Our
work here identifies TRIM71 as a novel gene associated with
human male infertility and uncovers a novel role for TRIM71 in
the embryonic development of the germline.
RESULTS
Trim71 Is Expressed in Spermatogonial
Stem Cells and Is Essential for Mouse
Fertility
Mice carrying a Trim71 homozygous deletion (KO, Trim71−/−)
die during embryonic development (Supplementary Figure 1A;
Schulman et al., 2008; Cuevas et al., 2015). In contrast, Trim71
heterozygous mice (HET, Trim71fl/−) are viable and fertile,
although significantly smaller in length and weight than wild type
(WT, Trim71fl/fl) littermates (Supplementary Figures 1B,C). We
detected Trim71 expression in the testes – but not in other
organs such as heart or kidney – of wild type and heterozygous
adult mice, with Trim71 mRNA levels decreased in the testes
of heterozygous mice (Figure 1A). We then measured the
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FIGURE 1 | Trim71 is expressed in spermatogonial stem cells (SSCs) of adult fertile mice. (A) qRT-PCR of Trim71 relative to Hprt housekeeping gene in testis, kidney
and heart of wild type (WT, Trim71fl/fl ) and Trim71 heterozygous (HET, Trim71fl/−) adult male mice (10–14 weeks old), normalized to Trim71 relative levels in wild type
murine ESCs (nd, not detected). Error bars represent SD (n = 3). (B) Organ weight [mg] relative to total body weight [g] of testis, kidney and heart of wild type (WT,
Trim71fl/fl ) and Trim71 heterozygous (HET, Trim71fl/−) male adult mice (10–14 weeks old). Graphs represent Tukey plots (n = 14–16). ***P-value < 0.005, ns,
non-significant (unpaired Student’s t-test). (C) Epididymal sperm counts in wild type (WT, Trim71fl/fl ) and Trim71 heterozygous (HET, Trim71fl/−) male adult mice
(10–14 weeks old). ***P-value < 0.005 (unpaired Student’s t-test). (D) qRT-PCR of Trim71, the SSC markers Sall4 and Lin28a, and the differentiating spermatogonia
marker Lin28b, relative to Hprt housekeeping gene in testes cell suspension before (total cells) and after THY1.2 MACS (THY1.2+/− cells). Error bars represent
(Continued)
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FIGURE 1 | Continued
SD (n = 3). (E) Representative flow cytometry scatter plots of testes cell suspension before (total cells) and after THY1.2 MACS (THY1.2+/− cells). (F) tSNE plot
(t-distributed stochastic neighbor embedding) of single-cell transcriptome data (scRNA-seq) from mouse testes as published by Hermann et al. (2018). Each dot
represents a single cell and is colored according to its cluster identity as indicated on the figure key. (G) Expression pattern of Trim71 and (H) Sall4, Lin28a and
Lin28b projected on the tSNE plot of the mouse scRNA-seq dataset. Red indicates high expression and gray indicates low or no expression, as shown by the figure
key. See also Supplementary Figures 1, 2.
weight of several organs relative to the total body weight,
and observed that testes – but neither heart nor kidney –
were significantly smaller in heterozygous males compared to
wild type males (Figure 1B). Accordingly, sperm counts were
significantly reduced in adult heterozygous males (Figure 1C).
These data suggested that Trim71 expression levels are important
for male gonad development and revealed a haploinsufficiency of
Trim71 in mice.
Since TRIM71 is usually expressed in undifferentiated cells,
we hypothesized that its expression in mice testes is present in
undifferentiated spermatogonia, also known as spermatogonial
stem cells (SSCs). To validate this hypothesis, we used wild
type testes cell suspensions to enrich SSCs (THY1.2 +) via
magnetic-activated cell sorting (MACS) (Liao et al., 2016). We
found an increase of Trim71 mRNA as well as the mRNAs
of the known murine SSC-specific markers Sall4 (Gassei and
Orwig, 2013) and Lin28a (Zheng et al., 2009) – but not the
differentiating spermatogonia marker Lin28b (Gaytan et al.,
2013) – in the THY1.2+ enriched cell population (Figures 1D,E).
This result indicated that Trim71 expression in adult mouse testes
is enriched in SSCs. Indeed, single-cell RNA sequencing analysis
of mouse and human adult testicular tissue confirmed a restricted
expression of Trim71 in SSCs (Figures 1F–H and Supplementary
Figure 2; Hermann et al., 2018).
To study the function of TRIM71 in male gonad development,
a germline-specific Trim71 conditional knockout mouse (cKO)
was generated with the Cre recombinase expressed under
the promoter of the early PGC marker Nanos3 (Suzuki
et al., 2008; Supplementary Figure 3A). For a first functional
evaluation, adult cKO mice (Trim71fl/−; Nanos3Cre/+) were
crossed with wild type (Trim71+/+) mice. Trim71 deficiency
in the germline results in infertility in both sexes, as neither
cKO males nor females were able to produce offspring after
numerous mating attempts over the course of several months
(Supplementary Figure 3B).
Germline-Specific Trim71 cKO Male Mice
Display a Sertoli Cell-Only (SCO)-Like
Phenotype
Macroscopic analysis of cKO male and female reproductive
organs revealed a dramatic reduction in testis and ovary size,
respectively (Figures 2A–C and Supplementary Figure 3C).
Hematoxylin and eosin (H&E) staining of adult male testis cross-
sections showed that most seminiferous tubules in cKO testes
were lacking signs of spermatogenesis (Figure 2D). Furthermore,
immunofluorescence staining of germ cells (GCNA1 Koshimizu
et al., 1995; Tanaka et al., 1998) and Sertoli cells (WT1 Mundlos
et al., 1993) showed a dramatic reduction of GCNA + cells in
cKO mice (Figures 2E,F). Accordingly, the expression of murine
SSC-specific markers Oct4, Sall4 and Lin28a, as well as the
differentiating spermatogonia marker Lin28b, was dramatically
reduced in whole testis RNA of cKO mice (Figure 2G),
representing the deficit of germ cells in these mice.
This phenotype is reminiscent of a human condition known as
Sertoli cell-only (SCO) phenotype, which is a specific type of non-
obstructive azoospermia characterized by a total or substantial
absence of germ cells in the seminiferous tubules, and whose
causes remain mostly unknown (Tüttelmann et al., 2011, 2018;
Koc et al., 2019). Our results here suggest that Trim71 cKO male
mice display an SCO-like phenotype with most seminiferous
tubules lacking germ cells.
Infertility in Germline-Specific Trim71
cKO Male Mice Has an Embryonic Origin
To investigate the origin of infertility in Trim71 cKO mice,
we first analyzed available datasets for the expression of
Trim71 in murine male and female gonads. While Trim71
expression in males is present in both fetal and adult testes,
Trim71 expression in females is detected in fetal ovaries
but not in adult ovaries (Supplementary Figure 4A; Han
et al., 2018). These results were confirmed by western blot
comparing TRIM71 expression in adult testes and ovaries of
wild type and Trim71 cKO mice (Supplementary Figure 4B).
Such an expression pattern may indicate that TRIM71 fulfills
embryonic and postnatal functions in the male germline, but
only embryonic functions in the female germline. Because a
postnatal function of TRIM71 in adult mouse spermatogenesis
has already been described (Du et al., 2020), we decided to
focus on the possible TRIM71 function during embryonic
germline development. As Nanos3 expression in mice embryos
is detected as early as E7.5 during PGC specification (Tsuda
et al., 2003), the infertility observed in both male and female
Trim71 cKO mice may reflect a function of TRIM71 in
an early stage of germ cell development. Thus, we next
analyzed available datasets for Trim71 expression in murine
fetal gonads. The expression of Trim71 followed a similar
pattern for male and female gonads during different mouse
developmental stages (Supplementary Figure 4C; Soh et al.,
2015; Zhao et al., 2018) which correlated with Trim71 expression
in isolated male and female germ cells at the same stages
(Supplementary Figure 4D; Seisenberger et al., 2012). This
expression pattern supports a possible role for TRIM71 in
germ cell development. In order to determine whether the
deficit of germ cells observed in adult Trim71 cKO male
mice derives from defects during embryonic development, we
conducted H&E staining and GCNA1-WT1 immunostaining
on testis cross-sections from neonatal (P0.5) male mice
(Figures 3A,B). Indeed, the SCO-like phenotype previously
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observed in adult male cKO mice was already apparent in
neonatal cKO mice as shown by a reduction in gonocyte-
containing seminiferous tubules (Figures 3B,C). These results
confirm that Trim71 expression during embryonic development
is required for the generation and/or maintenance of the male
germline before birth.
In vitro PGC Specification Reveals
Reduced Numbers of PGCLCs Derived
From Trim71-Deficient ESCs
In order to determine whether Trim71 deficiency causes PGC
specification defects, wild type (WT, Trim71fl/fl) and Trim71
FIGURE 2 | Continued
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FIGURE 2 | Continued
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FIGURE 2 | Germline-specific Trim71 cKO male mice present a Sertoli cell-only (SCO) phenotype. (A) Representative images of ovaries and (B) testes of adult wild
type (WT, Trim71+/+; Nanos3Cre/+), germline-specific Trim71 heterozygous (cHET, Trim71fl/+; Nanos3Cre/+) and germline-specific Trim71 knockout (cKO,
Trim71fl/−; Nanos3Cre/+) mice. Scale bars represent 2 mm. (C) Testis weight [mg] relative to total body weight [g] of wild type (WT’), Trim71 heterozygous (HET’) and
germline-specific Trim71 knockout (cKO) mice, summarized from Supplementary Figure 2C, joining several Nanos3 genotypes per Trim71 genotype. Error bars
represent SD (n=8–29). ***P-value < 0.005 (one-way ANOVA, Tukey’s test). (D) Representative H&E stainings on paraffin testes cross-sections from adult wild type
(WT, Trim71+/+; Nanos3Cre/+), germline-specific Trim71 heterozygous (cHET, Trim71fl/+; Nanos3Cre/+) and germline-specific Trim71 knockout (cKO, Trim71fl/−;
Nanos3Cre/+) mice. Seminiferous tubules with a defective morphology are marked with an asterisk (*) in 10x magnification images. Scale bars represent 200, 100,
and 20 µm in 2.5×, 10×, and 40× magnifications, respectively. (E) Representative immunofluorescence stainings on testes cryosections from adult wild type (WT,
Trim71+/+; Nanos3Cre/+), germline-specific Trim71 heterozygous (cHET, Trim71fl/+; Nanos3Cre/+) and germline-specific Trim71 knockout (cKO, Trim71fl/−;
Nanos3Cre/+) mice. Images show co-staining with GCNA1 (germ cells), WT1 (Sertoli cells) and DAPI (nuclei). For each genotype two regions – indicated as I and II –
are depicted in higher magnification. Scale bars represent 500 µm for complete testes cross-sections and 100 µm for the magnification images. (F) Quantification of
seminiferous tubules (ST) containing GCNA+ cells per testis cross-section from E, depicted as percentages. Error bars represent SD (n = 3). ***P-value < 0.005, ns,
non-significant (unpaired Student’s t-test). (G) qRT-PCR of Trim71, the murine SSC markers Sall4, Lin28a and Oct4, and the differentiating spermatogonia marker
Lin28b, relative to Hprt housekeeping gene in whole testis RNA of wild type (WT, Trim71+/+; Nanos3Cre/+), germline-specific Trim71 heterozygous (cHET,
Trim71fl/+; Nanos3Cre/+) and germline-specific Trim71 knockout (cKO, Trim71fl/−; Nanos3Cre/+) male adult mice. Error bars represent SD (n=3−6).
***P-value < 0.005; ***P-value < 0.01; *P-value < 0.05; ns, non-significant (unpaired Student’s t-test). See also Supplementary Figures 3, 4.
knockout (KO, Trim71−/−) murine ESCs (Mitschka et al.,
2015) were differentiated into PGC-like cells (PGCLCs) in vitro
as previously described (Hayashi et al., 2011). In short, ESCs
(d0) growing under naïve conditions were primed to epiblast-
like cells (EpiLCs) (d2) for two days in monolayer culture
and differentiated into PGCLCs (d8) for six more days in the
presence of BMP4 while growing as spheroids (Supplementary
Figure 5A). ESCs (d0) represent in vivo embryonic stem cells
of the blastocyst’s inner cell mass at E3.5-4.5 while EpiLCs (d2)
represent in vivo epiblast stem cells (EpiSCs) at E5.5-6.5, and
PGCLCs (d8) correspond to in vivo PGCs at E9.5 (Hayashi
et al., 2011). Thus, several markers were measured in bulk cell
populations at d0, d2 and d8 to monitor the differentiation
process (Supplementary Figure 6). Of note, these experiments
are rather sensitive to small variations in experimental conditions
and need to be interpreted with caution.
Both WT and Trim71 KO ESCs were primed to EpiLCs as
shown by a decrease of the naïve pluripotency marker Klf4 (Guo
et al., 2009; Hayashi et al., 2011) and a simultaneous increase
of the primed pluripotency epiblast-specific marker Dnmt3b
(Hayashi et al., 2011; Veillard et al., 2014) at d2 (Supplementary
Figures 6A,B). The subsequent Dnmt3b downregulation
observed at d8 was indicative of a successful specification
induction by BMP4, as the early PGC marker Prdm14 represses
Dnmt3b to enable PGC epigenetic reprogramming (Grabole
et al., 2013; Seki, 2018). Accordingly, both WT and Trim71 KO
cells showed a significant upregulation of PGC-specific markers
at d8 compared to d2 including Prdm14, Prdm1/Blimp1 and
their downstream targets Tfap2c and Nanos3 (Supplementary
Figures 6C–F). However, the levels of Blimp1 at d8 were
significantly lower in Trim71 KO cells than in WT cells, an
effect that was also apparent – although not significant – for
Nanos3. Importantly, while an upregulation of the early PGC
marker Nanos3 (Tsuda et al., 2003) was already observable
at d8, the expression of the late PGC marker Ddx4/Vasa
(Fujiwara et al., 1994; Tanaka et al., 2000) was not increased
(Supplementary Figure 6G), indicating that the in vitro-
generated PGCLCs represent in vivo PGCs prior to the time point
of Ddx4 expression (E10.5), as expected (Hayashi et al., 2011).
In order to estimate the number of PGCLCs specified from
WT and Trim71 KO ESCs, d8-bulk populations were stained for
the surface markers ITGB3/CD61 (PE-Cy7) and SSEA-1/CD15
(APC) – previously reported to unequivocally identify PGCLCs
(Hayashi et al., 2011) – and were analyzed by flow cytometry.
We found that the number of PGCLCs derived from Trim71-
deficient ESCs was reduced by about 25% (Supplementary
Figures 5B,C). A significant decrease of the PGC-specific marker
SSEA-1/CD15 (APC) – but not of ITGB3/CD61 (PE-Cy7) – was
also observed in PGCLCs derived from Trim71-deficient ESCs
(Supplementary Figures 5D,E). However, these stainings do not
show the expected distinct PGCLC population (Hayashi et al.,
2011), which might be indicative of an incomplete induction.
Of note, Oct4 is required for the maintenance of PGCs after
their specification (Kehler et al., 2004). The highest expression
of Oct4 in the mouse embryo is observed in the early blastocyst
and decreases progressively in the epiblast upon gastrulation
until being restricted to PGCs at E7.5 (Rosner et al., 1990;
Ecsedi and Grosshans, 2013). Accordingly, we detected a high
Oct4 expression in ESCs (d0) which significantly decreased
upon priming to EpiLCs (d2) and was maintained in PGCLCs
(d8) upon specification (Supplementary Figure 6H). A similar
pattern was observed for Trim71 expression in WT cells
(Supplementary Figure 6I) with a decrease in its mRNA level
after priming (d2) and a sustained expression in PGCLCs (d8).
While our results have revealed a moderate reduction in the
number of Trim71-deficient PGCLCs upon induction, we believe
that this cannot fully explain the dramatic phenotype observed
in Trim71 cKO mice. This, together with the sustained Trim71
expression in PGCLCs at d8, suggests a further role for TRIM71
downstream of PGC specification.
TRIM71 Deficiency Does Not Impair
in vivo Migration of PGCs Toward the
Genital Ridges
After specification, PGCs migrate along the hindgut toward the
genital ridges (Tam and Snow, 1981; Anderson et al., 2000).
Thus, we next investigated whether TRIM71 is required for
PGC migration in vivo. To this end, we used full Trim71
KO (Trim71−/−) embryos resulting from the mating of
full heterozygous (Trim71fl/−) animals in order to exclude
an incomplete Trim71 deletion at this stage resulting from
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FIGURE 3 | Continued
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FIGURE 3 | Infertility in germline-specific Trim71 cKO male mice has an embryonic origin. (A) Representative H&E stainings on paraffin testes cross-sections from
neonatal (P0.5) wild type (WT, Trim71+/+; Nanos3Cre/+), germline-specific Trim71 heterozygous (cHET, Trim71fl/+; Nanos3Cre/+) and germline-specific Trim71
knockout (cKO, Trim71fl/−; Nanos3Cre/+) male mice. Gonocytes within the seminiferous tubules are marked with a green arrow head, and gonocyte-lacking
seminiferous tubules are marked with a yellow asterisk (*) in 40x magnification images. Scale bars represent 100 and 20 µm in 10× and 40× magnifications,
respectively. (B) Representative immunofluorescence stainings on testes cryo-sections from neonatal (P0.5) wild type (WT, Trim71+/+; Nanos3Cre/+),
germline-specific Trim71 heterozygous (cHET, Trim71fl/+; Nanos3Cre/+) and germline-specific Trim71 knockout (cKO, Trim71fl/−; Nanos3Cre/+) male mice. Images
show co-staining with GCNA1 (gonocytes), WT1 (Sertoli cells) and DAPI (nuclei). Scale bars represent 200 µm. (C) Quantification of seminiferous tubules (ST)
containing GCNA+ cells per testis cross-section from B, depicted as percentages. Error bars represent SD (n=3). *P-value < 0.05, ns, non-significant (unpaired
Student’s t-test). See also Supplementary Figures 4–6.
an insufficient Nanos3-driven Cre expression. Wild type
(Trim71fl/fl) and full KO (Trim71−/−) embryos at stages
E8.5-8.75 were dissected to isolate the hindgut and alkaline
phosphatase (AP)-positive PGCs were stained. PGCs were
detected in close proximity to the allantois in both wild type and
Trim71-deficient embryos (Supplementary Figure 7). Although
our AP-stainings do not provide quantitative information, they
clearly show that Trim71 expression is not essential for migration
of PGCs toward the genital ridges and furthermore reinforce the
notion that no major PGC specification defects are apparent,
as already suggested by our PGCLC induction experiments.
Thus, TRIM71 likely affects germ cell development at later
embryonic stages.
TRIM71 Controls Proliferation in the
PGC-Like in vitro Model Cell Line
TCam-2
After arriving at the genital ridges, the PGC founder population
strongly increases in numbers before undergoing sex
determination (Tam and Snow, 1981; Anderson et al., 2000;
Bowles and Koopman, 2010; Ewen and Koopman, 2010). Since
TRIM71 is known to regulate proliferation in several cell lines
(Chen et al., 2013; Ren et al., 2018; Hu et al., 2019; Torres-
Fernández et al., 2019), we next wanted to investigate whether
TRIM71 may control proliferation also in PGCs. Because the
isolation of sufficient PGCs from genital ridges for its absolute
reliable quantification is technically very challenging, we used
the human GCT-derived seminoma cell line TCam-2, which is
a widely accepted in vitro PGC model (Irie et al., 2015; Sugawa
et al., 2015; Nettersheim et al., 2016a,b,c; Mitsunaga et al., 2017;
Müller et al., 2020) and expresses high TRIM71 levels, similar
to other GCT-derived cell lines (Supplementary Figure 8A). To
this end, we knocked down (KD) TRIM71 with two different
siRNAs (Figure 4A), and monitored the increase in cell numbers
over time (Figure 4B). Indeed, TRIM71 KD cells proliferated
significantly slower in the course of the experiment, as shown by
area under curve (AUC) measurements (Figure 4C). Consistent
with our previous observations in PGCLCs, TRIM71 KD
TCam-2 cells showed a significant downregulation of BLIMP1
and NANOS3, while TFAP2C and DDX4 remained unaltered
(Figures 4D–G). Although our data do not provide evidence for
a reduction in PGC proliferation in vivo, these results suggest
that TRIM71 may be important for the expansion of the germ
cell pool during embryogenesis, which could be an explanation
for the reduction of male gonocytes observed in neonatal
Trim71 cKO mice.
TRIM71 Controls Proliferation in the
Germline-Derived Tumor Cell Line NCCIT
The failure of male PGCs to further differentiate into gametes
can lead to the development of testicular GCT (TGCT) (Raman
et al., 2005; Looijenga et al., 2010; Zorrilla and Yatsenko,
2013). TGCT can be divided into three groups: (I) tumors
of newborns and infants (teratomas and yolk sac tumors),
(II) tumors of adolescents and young adults (seminomas and
non-seminomas) and (III) spermatocytic seminoma of elderly
men (≥ 50 years) (Oosterhuis and Looijenga, 2005). TRIM71
is highly expressed in several GCT-derived cell lines (Rybak
et al., 2009; Chang et al., 2012; Torres-Fernández et al., 2019)
(Supplementary Figure 8A), and is upregulated in TGCT
seminoma and non-seminoma patients (Tang et al., 2017;
Supplementary Figures 8B–D). Since we have shown that
TRIM71 controls proliferation of seminoma TCam-2 cells, we
evaluated whether TRIM71 could also control proliferation
in the GCT-derived non-seminoma cell line NCCIT. Because
TRIM71 is strongly expressed in NCCIT cells (Supplementary
Figure 8A) and we did not achieve a satisfying TRIM71
depletion via KD (data not shown), we generated TRIM71
frameshift mutations via CRISPR/Cas9. To this end, we used
two different single guide RNAs (sgRNA), one targeting the
N-terminal RING domain and another targeting the C-terminal
NHL domain (Supplementary Figure 8E). For the RING sgRNA
(1RING), the generation of single NCCIT clones strikingly
showed that an 83 kDa N-truncated RINGless version of TRIM71
is generated from the use of an alternative in-frame ATG codon
present downstream of the targeting region (Supplementary
Figure 8F). For the NHL sgRNA (1NHL6), generation of
single clones showed that the resultant protein was either
unstable or had a C-terminal truncation of the last NHL repeat
(Supplementary Figure 8G), a mutation which is already known
to mimic the full KO phenotype in vivo (Schulman et al.,
2008) and to impair mRNA binding and repression in vitro
(Torres-Fernández et al., 2019).
Single cell clones often have a selection bias toward
robust in vitro proliferation and survival. In order to study
TRIM71-dependent cell proliferation in an unbiased manner,
we analyzed cell population dynamics during in vitro growth
competition assays using non-clonal mixed pools of wild
type and TRIM71 mutant cells. To this end, NCCIT cells
were mock-transfected with an empty vector (EV) or with
TRIM71-targeting vectors (1RING or 1NHL6) and sorted
for Cas9-GFP + cells. Bulk-transfected EV (wild type) and
1RING/1NHL6 (TRIM71 mutant) NCCIT pure populations
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FIGURE 4 | TRIM71 controls proliferation in the in vitro PGC-like model cell line TCam-2. (A) RT-qPCR measurement of TRIM71 in wild type (siCtrl) and TRIM71 KD
(siTRIM71 #1 and siTRIM71 #2) TCam-2 cells 72 h post-transfection (n = 3). (B) Proliferation of wild type (siCtrl) and TRIM71 KD (siTRIM71 #1 and siTRIM71 #2)
TCam-2 cells depicting the increase in cell numbers over time after transfecting them with siRNAs and seeding them in equal numbers (d0) (n = 5). (C) Area under
curve (AUC) measurements for the proliferation curves depicted in B (n = 5). (D–G) RT-qPCR measurements for the indicated PGC markers in wild type (siCtrl) and
TRIM71 knockdown (siTRIM71 #1 and siTRIM71 #2) TCam-2 cells 72 h post-transfection (n=3–6). For all RT-qPCRs, the housekeeping gene 18S rRNA was used
for normalization. For all graphs, error bars represent the SEM. ***P-value < 0.005, **P-value < 0.01 (unpaired Student’s t-test). See also Supplementary Figure 8.
(Supplementary Figures 9A,B) were mixed in a 1:1 ratio. We
then evaluated changes in the distribution of single reads via NGS
(Illumina MiSeq system) (Ravi et al., 2018) for wild type and
TRIM71 mutant alleles over a time period of 21 days and classified
them as wild type reads, reads with TRIM71 frameshift (loss-of-
function) mutations and reads with TRIM71 in-frame mutations
(Figure 5). As a negative control, pure wild type NCCIT (EV)
cell populations were analyzed at day 0 and day 21, showing
no relevant changes in allele distribution (Supplementary
Figures 9C,D). In contrast, the percentages of alleles with
TRIM71 frameshift mutations dropped ~2-fold (from 11.34% to
5.96%) for NCCIT 1RING cells within 21 days (Figure 5A) and
~13-fold (from 32.46% to 2.53%) for NCCIT 1NHL6 cells in the
same time period (Figure 5B). Interestingly, TRIM71 in-frame
mutations also resulted in a growth disadvantage, although to a
lesser degree in each case (Figures 5A,B).
In the course of these growth competition assays with NCCIT
cells, we neither observed morphological changes indicative
of differentiation nor signs of abnormal cell death upon
regular media change, suggesting that the observed changes in
population dynamics may derive from TRIM71-mediated control
of proliferation. We then conducted proliferation assays on
individual 1RING and 1NHL6 NCCIT clones for confirmation.
This time, we employed the eFluor670 proliferation dye to stain
NCCIT cells (d0) and measured the loss of fluorescence intensity
over time as a readout for proliferation. While eFluor670
(APC) staining was comparable for wild type (EV Ctrl) and
TRIM71 mutant (1RING or 1NHL6) NCCIT cells at the
Frontiers in Cell and Developmental Biology | www.frontiersin.org 10 May 2021 | Volume 9 | Article 658966
fcell-09-658966 May 10, 2021 Time: 17:3 # 11
Torres-Fernández et al. TRIM71 in Embryonic Germline Development
FIGURE 5 | NCCIT cells with TRIM71 mutations show population maintenance defects in growth competition assays. (A) Pie charts showing allele frequencies for
wild type (EV) and TRIM71 RING mutant (1RING) or (B) TRIM71 NHL mutant (1NHL6) NCCIT cells obtained at different time points during growth competition
assays. For the assay, NCCIT wild type cells (EV) were mixed 1:1 with either TRIM71 RING mutant (1RING) or TRIM71 NHL mutant (1NHL6) NCCIT cells and directly
analyzed (d0) before their culturing, following by subsequent analysis at several time points (d3, d7, d14, and d21). Allele frequency was analyzed via NGS using the
Illumina MiSeq platform. For TRIM71 mutant alleles, reads with in-frame mutations and frameshift mutations (loss-of-function) in each respective domain (RING or
NHL) are depicted. The total number of sequencing reads for each time point is indicated under each respective pie chart. See also Supplementary Figures 8–10.
beginning of the experiment (d0), a retardation of eFluor670
(APC) histogram could be observed for both TRIM71 1RING
and 1NHL6 NCCIT cells at the end of the experiment (d4),
revealing proliferation defects in TRIM71 mutant NCCIT cells
(Supplementary Figures 10A,B). Based on the fluorescence
intensity of the eFluor670 dye at d0 and d4, and assuming
that fluorescence intensity halves upon every cell division, the
number of cell divisions as well as the average duration of the
cell cycle can be estimated (Supplementary Figures 10C,D).
The cell cycles of 1RING and 1NHL6 mutants were 1.68 h
and 3.94 h longer, respectively, than that of wild type NCCIT
cells. Such a prolongation of the cell cycle corresponds to an
11.2% and 25.2% reduction in proliferation for 1RING and
1NHL6 mutants, respectively. The stronger effect of the 1NHL6
mutant on proliferation may be due to the regulation of the cell
cycle inhibitor CDKN1A (Supplementary Figure 10E), which
is known to be dependent on TRIM71’s NHL domain and
independent of its RING domain (Torres-Fernández et al., 2019).
These results collectively demonstrate that TRIM71 is involved
in the control of proliferation in NCCIT cells, and are consistent
with the data obtained with TCam-2 cells as well as with
previous studies involving other tumor cell lines (Chen et al.,
Frontiers in Cell and Developmental Biology | www.frontiersin.org 11 May 2021 | Volume 9 | Article 658966
fcell-09-658966 May 10, 2021 Time: 17:3 # 12
Torres-Fernández et al. TRIM71 in Embryonic Germline Development
2013; Ren et al., 2018; Hu et al., 2019; Torres-Fernández et al.,
2019). Our work thereby confirms a role for TRIM71 supporting
the proliferation of GCT-derived cells. Along with the elevated
TRIM71 expression observed in TGCT patients, these findings
suggest that TRIM71 may not only affect germ cell proliferation
during developmental processes, but may also contribute to the
malignancy of GCT.
We then measured the expression of the PGC-specific markers
NANOS3 and BLIMP1 in NCCIT wild type and TRIM71 mutant
cells. In line with our previous findings in Trim71 KO PGCLCs
and TRIM71 KD TCam-2 cells, NANOS3 was downregulated
in TRIM71 1NHL6 mutant NCCIT cells (Supplementary
Figure 10F) and BLIMP1 was downregulated in both 1RING and
1NHL6 mutants (Supplementary Figure 10G). Interestingly,
we and others recently found that TRIM71 is not only
an mRNA repressor, but is also capable of positive mRNA
regulation via direct binding and stabilization (Foster et al.,
2020; Torres-Fernández et al., 2021). Thus, we checked several
published datasets for Blimp1 and Nanos3 expression and
mRNA binding. In accordance with our data, Blimp1 was found
consistently downregulated in Trim71 KO, RING mutant and
NHL mutant ESCs and its mRNA was co-precipitated with
TRIM71 in RNA-IPs (Supplementary Figure 10H; Welte et al.,
2019) while Nanos3 mRNA was not (data not shown). Similarly,
BLIMP1 was downregulated in TRIM71 KO hepatocellular
carcinoma (HCC) cells (Supplementary Figure 10I; Welte
et al., 2019), and BLIMP1 mRNA was also co-precipitated with
TRIM71 in HCC cells (Supplementary Figure 10I; Foster et al.,
2020). These results suggested a post-transcriptional regulation
of Blimp1 mRNA mediated by TRIM71, which is known to
directly interact with mRNAs via conserved RNA hairpins
(Kumari et al., 2018; Torres-Fernández et al., 2019; Welte et al.,
2019). Supporting the RNA-IP binding data, several TRIM71-
binding hairpins were found located along the Blimp1 mRNA
(Supplementary Figure 10J) while no hairpins were identified
along the Nanos3 mRNA (Welte et al., 2019). The ability of
TRIM71 to positively regulate directly bound mRNAs has been
reported to depend on both the RING and NHL domains, and
was achieved via TRIM71-mediated repression of let-7 miRNA
(Torres-Fernández et al., 2021). Interestingly, this mechanism
was observed in both ESCs and HCC cells (Torres-Fernández
et al., 2021). Thus, it is possible that TRIM71 regulates Blimp1
expression via this mechanism, since (i) Blimp1 is a known let-
7 target (West et al., 2009), (ii) TRIM71 is able to directly bind
Blimp1 mRNA and (iii) TRIM71-mediated Blimp1 regulation
depends on both the RING and NHL domains.
Exome Sequencing Data Identifies
TRIM71 Variants in Infertile Men With
Severely Impaired Spermatogenesis
The causes of the SCO phenotype in men remain poorly
understood (Tüttelmann et al., 2011; Tüttelmann et al., 2018;
Koc et al., 2019). In order to identify novel associated genes, we
utilized exome sequencing data of 247 SCO subjects belonging to
the Male Reproductive Genomics (MERGE) study. We employed
our in-house software Sciobase and our newly developed software
Haystack to analyze loss-of-function (LoF) variants. After strict
filtering based on quality criteria, minor allele frequency (MAF)
in the general population, high expression in human testes
(GTEx) and absence of LoF variants in individuals with complete
spermatogenesis, we identified a total of 721 genes with LoF
variants specifically found in SCO patients (Figures 6A–C). Via
this independent and unbiased approach, we found TRIM71 to
be present among these genes, revealing a possible association
with human male infertility. This finding is strongly supported by
our previous data showing that TRIM71 deficiency results in an
SCO-like phenotype in male mice. Of note, most of the identified
human genes carried LoF variants in only one patient within
the studied cohort and none of the identified genes carried LoF
variants in more than four individuals, indicating that the SCO
phenotype is highly heterogeneous (Figure 6B). Similar results
were observed upon inclusion of genes with lower expression in
the testis (Figure 6C).
For a further evaluation of TRIM71 as a candidate gene
associated with human male infertility, we screened 908 infertile
patients - including those with SCO from MERGE - for variants
in TRIM71. We identified 11 different rare (MAF ≤ 0.001)
heterozygous TRIM71 variants, including the aforementioned
LoF variant and 10 missense variants, present in a total of 14
infertile individuals with severely impaired spermatogenesis and
varying histological phenotypes (Figures 6D–F and Table 1).
The majority of subjects (11 out of 14) were azoospermic, and
some of them presented with reduced testicular volumes, elevated
luteinizing hormone (LH) levels, elevated follicle-stimulating
hormone (FSH) levels and/or reduced serum testosterone (T)
levels (Table 1), all signs of broad testicular dysfunction present
in 60% of azoospermic men (Tüttelmann et al., 2018).
Generally, although most of the identified missense variants
were classified as variants of uncertain significance according
to ACMG/AMP guidelines (Supplementary Table 1), TRIM71
seems to be rather intolerant to missense variation (Figure 6D;
Wiel et al., 2019). This was also indicated by a high Z score
value of 3.28 for TRIM71. The Z score is a metric computed
by gnomAD database and ranges from −5 to 5, with higher
values indicating an intolerance to variation and, therefore,
a higher likelihood for TRIM71 variants to disrupt TRIM71
function. Furthermore, parameters such as MAF or pathogenicity
prediction algorithms were used to estimate the reliability for
the association of each variant with male infertility (Table 1).
The conservation of the affected residues for each variant was
also evaluated (Supplementary Figure 11A). Four of the TRIM71
missense variants identified in infertile men were also found
in control subjects with complete spermatogenesis (n = 89)
or in a Dutch cohort of proven fathers (n = 5784), making
their association with male infertility rather unlikely (Figure 6E,
green). In contrast, other identified TRIM71 missense variants
were present in one patient each but neither in control subjects
nor in the Dutch cohort of proven fathers (Figure 6E, orange).
Of those, c.368T>C/p.(Val123Ala), c.803T>A/p.(Leu268His),
c.1070C>T/p.(Ala357Val) and c.1486C>T/p.(Arg496Cys) were
considered damaging by at least two out of four pathogenicity
prediction algorithms (Table 1), and the respective residues
for those variants were highly conserved among vertebrates
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FIGURE 6 | Continued
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FIGURE 6 | Exome sequencing in infertile SCO patients reveals an association of TRIM71 deficiency with human male infertility. (A) Filtering scheme detailing gene
prioritization of exome sequencing data from 247 individuals with Sertoli cell-only (SCO) phenotype using Sciobase and Haystack (see details in the section
“METHODS”). Gene numbers remaining after each filtering step are indicated in blue. Loss-of-function (LoF) variants include stop, frameshift, splice acceptor and
splice donor variants. gnomAD, Genome Aggregation Database; MAF, minor allele frequency; GTEx, Genotype-Tissue Expression Portal. (B) Percentages of genes
(total = 721, obtained at the end of the filtering process depicted in A) affected by LoF variants in 1–4 SCO patients. None of the genes carried LoF variants in more
than 4 patients in the SCO cohort (n = 247). (C) Percentages of genes (total = 1800, obtained at the end of the filtering process depicted in A, excluding “High
expression in testis - GTEx” filtering step) affected by LoF variants in 1-6 SCO patients. None of the genes carried LoF variants in more than 6 patients in the SCO
cohort (n = 247). (D) TRIM71 mutation tolerance landscape obtained from MetaDome (https://stuart.radboudumc.nl/metadome/). The graph displays missense over
synonymous variant ratios per position for the entire protein, based on gnomAD variants. I, intolerant; N, neutral; T, tolerant. (E) Schematic representation of TRIM71
domain structural organization depicting the location of the genetic variants identified in MERGE. Red, presumably pathogenic LoF variants; orange, missense
variants of uncertain significance; green, missense variants found also in proven fathers. (F) Periodic acid–Schiff stainings of testis sections obtained by testicular
biopsy from a control patient and an SCO patient (subject M364), who harbors the TRIM71 LoF variant c.224_240dup/p.(Gly81CysfsTer24) in heterozygosis. The
control section shows intact spermatogenesis (Spg, spermatogonia; Spc, spermatocytes; RS, round spermatids; ES, elongated spermatids) as opposed to subject
M364, whose histological evaluation revealed an SCO phenotype (exemplary Sertoli cells indicated by arrow heads) with several degenerated seminiferous tubules,
frequently including large vacuoles (V) and thickened basement membranes (BM). See also Table 1, Supplementary Figures 11, 12, and Supplementary
Tables 1, 2.
(Supplementary Figure 11A). Thus, these variants have a higher
likelihood of being associated with male infertility.
As an additional line of evidence, all patients carrying variants
in TRIM71 (Table 1) were evaluated for relevant variants in other
genes previously reported in association with male infertility
(n = 181, listed in Supplementary Table 2). Importantly,
one heterozygous frameshift variant was found for the gene
SYCP2 in patient M1686, who carries the TRIM71 variant
c.1070C>T/p.(Ala357Val). SYCP2 was recently associated with
male infertility (Schilit et al., 2019), and it is thus unlikely
that this patient’s TRIM71 variant alone is responsible for his
cryptozoospermia, but an oligogenic cause of his phenotype
cannot be ruled out. Furthermore, a heterozygous missense
variant for the gene NNT was identified in patient M1083,
who carries the TRIM71 variant c.1486C>T/p.(Arg496Cys). In
this case, the NNT missense variant is of unclear significance
according to ACMG/AMP guidelines, and its functional
contribution to the patients’ phenotype can therefore neither
be confirmed nor excluded at this point. Collectively, our
analysis leaves the TRIM71 variants c.368T>C/p.(Val123Ala) and
c.803T>A/p.(Leu268His) as the likeliest candidates for being
associated with male infertility.
Exome Sequencing Data Reveals an
Association of TRIM71 LoF Variants With
the SCO Phenotype
As mentioned above, a TRIM71 LoF variant -
c.224_240dup/p.(Gly81CysfsTer24) - was identified via exome
sequencing in subject M364, who presented with a clear SCO
phenotype (Figures 6E,F and Table 1). This variant consists
of a duplication of 17 nucleotides which generates a frameshift
resulting in a premature termination codon (PTC) downstream
of the RING domain (Supplementary Figure 11B). This
particular TRIM71 LoF variant has not been described in any
public database so far and was classified as likely pathogenic
according to ACMG/AMP guidelines (Supplementary Table 1).
Furthermore, the observed/expected (o/e) score computed
for TRIM71 in the gnomAD database was extremely low (o/e
score = 0.04, 90% confidence interval 0.01–0.17). The o/e score
compares the number of observed versus theoretically expected
LoF variants for a gene of interest. Without any selection
pressure applied, an o/e ratio of around 1 would be expected
for any given gene, whereas values below 0.35 are a rather clear
sign of selection pressure against LoF variants, likely leading
to haploinsufficiency intolerance. Furthermore, subject M364
carries neither additional LoF variants nor likely pathogenic
missense variants in any other known infertility-associated genes
(listed in Supplementary Table 2). This patient presented with
normal testicular volumes and LH levels, but increased FSH and
decreased testosterone levels (Table 1), as is often the case in
men with impaired spermatogenesis. Of note, no TRIM71 LoF
variants were found in the Dutch cohort of proven fathers, and
only one LoF variant was present in the exome data from 125,748
presumably healthy individuals from gnomAD (Karczewski et al.,
2020). This constitutes a significant enrichment of TRIM71 LoF
variants in the MERGE cohort (n = 908; p = 0.01) and an even
higher enrichment in the SCO subcohort (n = 247; p = 0.004),
supporting a reliable association of TRIM71 LoF variants with
human male infertility. Thus, the reported TRIM71 LoF variant is
likely the cause of subject M364’s SCO phenotype, underscoring
a haploinsufficiency of TRIM71 in human spermatogenesis.
In contrast, although sperm counts were strongly reduced
in TRIM71 heterozygous mice, these animals were fertile.
This discrepancy may be attributed to inherent mechanistic
differences between murine and human gametogenesis. Indeed,
it has been reported for multiple diseases that the modulation
of a specific gene can result in different severity and range of
symptoms for mice and humans (Elsea and Lucas, 2002).
In order to address the functionality of all identified TRIM71
variants, we overexpressed them in HEK293T cells to evaluate
protein stability via western blot analysis. Whereas all TRIM71
missense variants yield stable proteins, the LoF variant resulted
in a functional KO as expected, since no protein was detected
via western blot analysis for the respective LoF construct Flag-
dupPTC (Supplementary Figure 12A). We additionally tested
the ability of the different TRIM71 constructs to repress the
3′UTR of CDKN1A (Torres-Fernández et al., 2019) as well as
the activity of let-7 miRNA (Torres-Fernández et al., 2021) via
luciferase reporter assays in HEK293T cells. CDKN1A 3′UTR
repression was impaired for the Flag-dupPTC construct, and
significantly diminished for the G597S variant which affects
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TABLE 1 | TRIM71 variants identified in infertile men within the MERGE cohort.
Variant (cDNA) Variant (protein) Predicted
effecta







c.224_240dup p.(Gly81CysfsTer24) NA 0 M364 26; Germany Azoo/SCO 24/21 9 17.9 7.6
c.248C>T p.(Ala83Val) 10.2; B/T/N 0 M2118 33; Germany Crypto/NA 16/17 4.1 7.6 14.1
c.368T>C p.(Val123Ala) 18.5; D/D/D 0 M2110 43; Kazakstan Crypto/NA 19/17 5.5 6.2 14.9
c.553G>T p.(Ala185Ser) 0.01; B/T/N 0.0047 M1325 33; Germany Azoo/Hypo 7/8 4.6 6.8 15.6
c.553G>T p.(Ala185Ser) 0.01; B/T/N 0.0047 M1562 36; Germany Azoo/SCO 9/6 7.3 24.7 13.8
c.785G>C p.(Gly262Ala) 0.2; B/T/D 0 M2173 28, Turkey Azoo/SCO 13/18 2.9 8.3 17.7
c.803T>A p.(Leu268His) 15.6; D/T/D 0 M1793 33; Turkey Azoo/MeiA 15/15 6.3 8.4 15.3
c.1070C>T p.(Ala357Val) 23.2; B/T/D 0.0001 M1686 29; Romania Crypto/NA 17/16 9.5 7.1 39.7
c.1486C>T p.(Arg496Cys) 28.8; D/D/D 0.0001 M1083 36; Germany Azoo/NA 12/8 9.6 18.1 17.5
c.1549C>T p.(Arg517Cys) 23.4; D/T/D 0.0016 M468 34; Pakistan Azoo/MeiA 19/16 6.8 6.4 19.8
c.1613C>G p.(Ala538Gly) 14.4; B/T/D 0 M2069 29; Lebanon Azoo/NA 9/6 3.5 8.4 6.1
c.1789G>A p.(Gly597Ser) 30; D/D/D 0.0022 M244 31; Germany Azoo/MeiA 26/26 2.8 5.2 15.2
c.1789G>A p.(Gly597Ser) 30; D/D/D 0.0022 M754 32; Turkey Azoo/SCO 6/7 11 30.7 15.9
c.1789G>A p.(Gly597Ser) 30; D/D/D 0.0022 M2141 27; Turkey Azoo/Hypo 17/14 5.8 13.5 16.6
aPredicted effect of each TRIM71 variant estimated by four different pathogenicity prediction algorithms (CADD/PolyPhen2/SIFT/MutationTaster, shown in the same
order). For CADD, variants with values above 20 are more likely to be deleterious to protein function. For the rest, D, damaging/deleterious; T, tolerated; B, benign; N,
neutral; NA, not available.
bMAF (minor allele frequency) values derive from gnomAD and are considered rare if MAF < 0.001 when occurring in heterozygosis.
cSemen analysis was performed for all patients (Azoo, azoospermia; Crypto, cryptozoospermia), and if biopsies were available, patients’ phenotypes were also
histologically assessed (SCO, Sertoli cell-only phenotype; MeiA, meiotic arrest; Hypo, hypospermatogenesis).
dTesticular volumes (testis vol., right/left, ref. > 15 mL each; bold, values outside the normal range).
eLuteinizing hormone (LH, ref. 2-10 IU/L; bold, values outside the normal range).
f Follicle-stimulating hormone (FSH, ref. 1-7 IU/L; bold, values outside the normal range).
gTestosterone (T, ref. > 12 nmol/L; bold, values outside the normal range).
TRIM71’s NHL domain (Supplementary Figures 12B,C). The
ability of TRIM71 to derepress a luciferase reporter under
the control of a 3′UTR with multiple let-7 binding sites was
also abrogated for the Flag-dupPTC construct (Supplementary
Figures 12D,E). These assays collectively show that the TRIM71
LoF variant identified in the patient with SCO phenotype
yields a functional KO. Future experiments should determine
whether the here identified missense variants impair other
known TRIM71 functions (e.g., TRIM71’s E3 ubiquitin ligase
role) as well as determine their pathogenicity in the context of
human infertility.
DISCUSSION
TRIM71 is a stem cell-specific protein expressed early in
development and with an essential function for embryogenesis
(Schulman et al., 2005, 2008; Rybak et al., 2009; Cuevas
et al., 2015). Embryonic lethality in Trim71 full KO mice
is accompanied by neural tube closure defects, revealing also
a function of TRIM71 in the development of the nervous
system (Schulman et al., 2005, 2008; Rybak et al., 2009; Cuevas
et al., 2015). Indeed, TRIM71 is known to promote self-
renewal of neural progenitor cells (Chen et al., 2012), and
TRIM71 variants affecting its NHL domain have been associated
with human congenital hydrocephalus, a brain developmental
disease characterized by enlarged brain ventricles due to an
abnormal accumulation of cerebrospinal fluid (Furey et al., 2018).
Furthermore, TRIM71 has been connected with carcinogenesis
in several studies (Chen et al., 2013, 2019; Ren et al., 2018; Hu
et al., 2019; Torres-Fernández et al., 2019). Altogether, previous
research on TRIM71 has been mostly focused on embryonic and
neural stem cells as well as cancer cells. Our work here reports a
novel role for TRIM71 in the development of germ cells during
embryogenesis with crucial implications in murine and possibly
human fertility.
In line with previous studies (Rybak et al., 2009; Du et al.,
2020), our work reveals an expression of Trim71 in adult mouse
testes which we found to be confined to SSCs in mice and human.
We showed that germline-specific ablation of Trim71 early in
mouse development causes a substantial reduction of gonad size
and infertility in both sexes. Further characterization of adult
Trim71 cKO mouse testes revealed a significant downregulation
of SSC-specific and spermatid markers caused by a strong
reduction in the number of developing germ cells, a condition
which in humans is known as Sertoli cell-only (SCO) phenotype
(Tüttelmann et al., 2011, 2018; Koc et al., 2019). Via exome
sequencing of human infertile men, we uncovered an association
of TRIM71 deficiency with the SCO phenotype.
In humans, infertility affects 10–15% of couples trying to
conceive (Zorrilla and Yatsenko, 2013). Male factors contribute
in about half of couples and usually genetic causes correlate
with a more severe spermatogenic impairment (Lee et al., 2011).
Lately, several genes have been identified as monogenic causes
for azoospermia due to meiotic arrest (e.g., TEX11 Yatsenko
et al., 2015, STAG3 Van Der Bijl et al., 2019, M1AP Wyrwoll
et al., 2020 and SHOC1 Krausz et al., 2020). However, the SCO
phenotype seems to be a highly heterogeneous condition, as
indicated by our data, making the identification of monogenic
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causes especially challenging. Our work uncovers TRIM71 as the
first monogenic cause for this condition, based on the SCO-
like phenotype observed in our germline-specific Trim71 cKO
mouse together with the TRIM71 LoF variant that we found
in an SCO patient. The finding of TRIM71 as a novel SCO
candidate gene is relevant in terms of patient care, as it may allow
future patients to be provided with a causal diagnosis for their
azoospermia, and the potential success of testicular biopsy and
sperm extraction with the aim to perform in vitro fertilization
could be predicted in advance.
In contrast to the convincing relevance of the TRIM71 LoF
variant, assessing the role of the identified rare TRIM71 missense
variants in infertile patients of varying histological phenotypes
is much more challenging. Of note, variants in the same gene
may cause a spectrum of histological phenotypes (Wyrwoll
et al., 2020). Although our analysis provides a prediction for the
pathogenicity of these variants, their functional effects on human
male fertility are yet of unclear significance and can be only
determined experimentally. Nevertheless, it is worth emphasizing
that most missense variants identified in TRIM71 cluster outside
of the NHL domain, as mutations affecting the NHL domain have
been proven to be highly deleterious (Slack et al., 2000; Kumari
et al., 2018) and compromise survival during early embryogenesis
(Schulman et al., 2008). Accordingly, we found that these
missense variants do not compromise NHL-dependent TRIM71
functions. Future experiments using these TRIM71 variants
should determine whether they functionally affect TRIM71’s E3
ubiquitin ligase role, and if so, how exactly TRIM71-mediated
ubiquitylation contributes to germ cell development.
Our germline-specific Trim71 cKO mouse model provided
further evidence for the role of Trim71 in germ cell development.
The SCO-like phenotype was already apparent in the testes
of neonatal (P0.5) cKO mice, indicating that TRIM71-induced
germline defects have an embryonic origin. However, early
developmental defects are likely amplified during postnatal
mitotic reactivation and pubertal spermatogenesis as described
by a recent work showing infertility in a different germline-
specific Trim71 knockout (Trim71−/fl; Ddx4Cre/+) mouse model
(Du et al., 2020). In contrast to our observations in Trim71fl/−;
Nanos3Cre/+ mice, defects in Trim71−/fl; Ddx4Cre/+ mice were
only detected in pubertal (P10) and adult (P56) mice, with
germ cell numbers not yet altered in neonatal (P1) mice (Du
et al., 2020). This discrepancy may result from an earlier Cre
recombinase expression in our cKO model, since Nanos3 is
expressed during PGC specification (E7.5) (Ginsburg et al., 1990;
Lawson et al., 1999; Tsuda et al., 2003), and Ddx4 is expressed
after colonization of the genital ridges (E10.5) (Fujiwara et al.,
1994; Tanaka et al., 2000). In fact, Ddx4-induced recombination
was previously reported to occur even after sex determination as
late as E15.0 (Gallardo et al., 2007). This might also explain why
Trim71fl/−; Ddx4Cre/+ females are fertile (Prof. Xin Wu, personal
communication, June 22, 2020), while we found Trim71fl/−;
Nanos3Cre/+ females to be sterile. Notably, studies in C. elegans
showed that the nematode homolog of TRIM71, LIN-41, is
required for normal oocyte growth and meiotic maturation,
with lin-41 depletion causing sterility in females (Spike et al.,
2014; Tsukamoto et al., 2017). Further studies are required to
characterize the function of TRIM71 in mammalian female gonad
development and fertility.
Although we do not exclude sex-specific functions of
TRIM71 in the germline, we found both male and female
Trim71 cKO mice to be infertile, suggesting that germ cell
developmental defects may occur prior to sex determination of
PGCs. Alternatively, TRIM71 deficiency may similarly affect male
and female germ cells after sex determination, since published
datasets revealed similar TRIM71 expression patterns in male and
female PGCs during development. Via in vitro differentiation of
ESCs into PGCLCs, we observed reduced numbers of Trim71-
deficient PGCLCs at the end of the specification process.
Although such a reduction in the PGCLC numbers would
underscore mild PGC specification defects of Trim71-deficient
cells, it could also result from a specific downregulation of
the PGC marker SSEA-1/CD15 which was used for PGCLC
staining, and which was found downregulated in Trim71 KO
PGCLCs. Furthermore, Trim71-deficient PGCLCs showed a
downregulation of Blimp1 and Nanos3, which are two well-
known master regulators of PGC development (Kurimoto et al.,
2008; Suzuki et al., 2008). Consistently, we also found reduced
levels of BLIMP1 and NANOS3 in TRIM71 KD TCam-2 cells
and TRIM71 mutant NCCIT cells. We furthermore presented
evidence suggesting that TRIM71-mediated BLIMP1 regulation
may be attributed to a recently reported novel role for TRIM71
in the repression of let-7 miRNA activity (Torres-Fernández
et al., 2021). In this context, it is worth mentioning that the
let-7-mediated regulation of Blimp1 plays an important role
in murine PGC development (West et al., 2009). Interestingly,
Trim71-deficient ESCs showed a premature upregulation of
differentiation-promoting miRNAs, including let-7 and several
gonad-specific miRNAs (Mitschka et al., 2015; Torres-Fernández
et al., 2021), highlighting a yet-unknown role for TRIM71-
mediated miRNA regulation in early gonad development. It is
however intriguing that TRIM71-mediated Blimp1 regulation
does not result in PGC specification or migration defects, as
BLIMP1 is well known to control early PGC functions (Ohinata
et al., 2005). At this point, we can only speculate that such
a moderate regulation of Blimp1 at early stages may induce,
for instance, epigenetic changes that may affect later stages of
germ cell development. Alternatively, TRIM71-mediated Blimp1
regulation may simply be more relevant at later stages, as the
expression of both TRIM71 and BLIMP1 is indeed sustained in
developing germ cells even after sex determination (Seisenberger
et al., 2012; Zhao et al., 2018).
Since Trim71 expression was still remarkably high in PGCLCs,
we aimed at investigating further roles of TRIM71 downstream
of PGC specification. While we excluded in vivo PGC migration
defects upon TRIM71 depletion, in vitro proliferation assays
with TCam-2 and NCCIT cells showed that TRIM71 actively
promotes proliferation of these GCT-derived cell lines. Given
the similarities of TCam-2 cells – and to a lesser extent of
NCCIT cells – with PGCs (Irie et al., 2015; Sugawa et al., 2015;
Nettersheim et al., 2016a,b,c; Mitsunaga et al., 2017; Müller et al.,
2020), our results suggest that TRIM71 may be involved in the
control of PGC proliferation after they reach the genital ridges,
when a significant expansion of the PGC pool occurs (Tam
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and Snow, 1981; Anderson et al., 2000; Bowles and Koopman,
2010; Ewen and Koopman, 2010). To strengthen this notion,
future experiments should investigate the role of TRIM71 in the
proliferation of post-migratory PGCs in vivo. Additionally, the
role of TRIM71 in the maintenance of the germline may extend
beyond proliferation control, as previous studies have shown
roles for TRIM71 not only in the control of proliferation (Chang
et al., 2012; Chen et al., 2012, 2013; Ren et al., 2018; Hu et al., 2019;
Torres-Fernández et al., 2019), but also during differentiation
(Loedige et al., 2013; Worringer et al., 2014; Mitschka et al., 2015)
and apoptosis (Nguyen et al., 2017; Chen et al., 2019; Hu et al.,
2019) in developmental and oncogenic contexts. Importantly, a
recent study described an impaired proliferation and an increased
apoptosis in adult mice primary SSCs upon Trim71 KD (Du et al.,
2020). Likewise, TRIM71 might also participate in the control
of the massive apoptotic waves that mitotically arrested male
PGCs/gonocytes undergo within the developing and neonatal
gonads (Wang et al., 1998).
In summary, we have shown that germline-specific Trim71
cKO mice are infertile, with males predominantly displaying
an SCO-like phenotype. We have identified TRIM71 variants in
infertile men with severely impaired spermatogenesis, including
a LoF variant in an SCO patient which was confirmed to
abrogate TRIM71 expression and function. Trim71-associated
infertility seems to originate during embryonic development,
since the SCO-like phenotype was already apparent in neonatal
P0.5 Trim71 cKO male mice and Trim71 expression in females
is restricted to fetal gonads. Our in vitro assays consistently
showed TRIM71-dependent changes in cell proliferation as
well as in the expression of important PGC regulatory factors,
suggesting that infertility in Trim71 cKO mice may be caused
by an impaired proliferation of germ cells. Altogether, our work
supports a novel role for TRIM71 in the embryonic development
of the germline as well as of germline-derived tumors or
GCT. Future unraveling of the molecular mechanisms by which
TRIM71 governs germ cell biology will shed further light on the
underlying causes of infertility. A deeper understanding of these
processes will contribute to the development of new diagnostic




All animal experiments were conducted in a licensed animal
facility in accordance with the German law on the protection
of experimental animals (the German animal welfare act), and
were approved (approval number 87-51.04.2011.A063) by local
authorities of the state of Nordrhein-Westfalen (Landesamt für
Natur-, Umwelt- und Verbraucherschutz NRW).
The generation of the full Trim71 KO mouse (Trim71fl/fl;
Rosa26-CreERT2) was previously described (Mitschka et al.,
2015). In order to generate a germline-specific Trim71 knockout
mouse, wild type females with floxed Trim71 alleles (WT,
Trim71fl/fl) were bred with male mice expressing the Cre
recombinase under the control of the endogenous Nanos3
promoter in heterozygosity (Nanos3Cre/+) (Suzuki et al., 2008).
The heterozygous Trim71−/+; Nanos3Cre/+ male offspring
was then crossed with wild type Trim71+/+ females to
produce Trim71 wild type animals with the Nanos3-Cre allele
in heterozygosity (WT, Trim71+/+; Nanos3Cre/+), or with
wild type Trim71fl/fl females to produce germline-specific
heterozygous (cHET, Trim71−/+; Nanos3Cre/+) and germline-
specific knockout (cKO, Trim71−/fl; Nanos3Cre/+) animals.
Genomic DNA Extraction and
Genotyping
Genomic DNA was extracted from adult mice tail or ear biopsies
or from mouse embryo yolk sacs by boiling the tissue in 50 mM
NaOH for 20 min followed by pH neutralization of the lysate with
1/4 of 1 M Tris-Cl, pH 8.0. A three-primer strategy was used for
PCR amplification of the Trim71 locus or the Nanos3 locus and
fragments were resolved on a 2% agarose gel. Primers used are
listed in Supplementary Table 3.
Epidydmal Sperm Counts
Cauda epididymis were isolated from 3-month-old male mice
and transferred into 0.5–1 ml of PBS pre-warmed at 35–
37◦C. Sperm release was achieved by performing multiple cauda
incisions followed by 10-min incubation at 35–37◦C to allow
the sperm swim out. The sperm suspension was then diluted
in water (1:15-1:40) and sperm count was determined using a
Neubauer hemocytometer.
Isolation of Spermatogonial Stem Cells
From Mouse Testes
Testes were isolated from 2-month-old male mice, and
seminiferous tubules were exposed by removing the tunica
albuginea. The tubules of several testes were pooled and
incubated in approximately 10 volumes of HBSS with calcium
and magnesium containing 1 mg/ml collagenase Type IV and 200
to 500 µg/ml DNAse I, followed by incubation at 37◦C under
gentle agitation for 15 min. The tubules were then washed three
times in 10 volumes of HBSS, followed by incubation at 37◦C
for 5 min in HBSS containing 0.25% trypsin and 150 µg/ml
DNAse I under gentle agitation. Trypsinization was stopped by
adding 20% FBS, and the cell suspension was filtered through
a 40 µm pore size nylon filter. The filtrate was centrifuged at
1000 rpm for 5 min at 4◦C and the cell pellet was resuspended in
PBS before cell counting. Magnetic-activated cell sorting (MACS)
was used to enrich THY1.2 + cells. To this end, 106 cells were
stained with 0.2 µg FITC-labeled anti-THY1.2/CD90.2 antibody
(BioLegend) for 15 min at 4◦C. The cells were then washed in
MACS-buffer (PBS supplemented with 2 mM EDTA and 0.5%
FBS) and incubated in a 1:5 dilution of anti-FITC microbeads
(Miltenyi) for 15 min at 4◦C before a final washing in MACS
buffer followed by centrifugation at 1000 rpm for 5 min at 4◦C.
The pellet was resuspended in 500 µl MACS buffer and loaded
on an AutoMACS device (Miltenyi) with the program set for
positive selection. The efficiency of enrichment was 8-fold as later
controlled by flow cytometry. The different cell populations were
then used for RNA extraction and qRT-PCR quantification.
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H&E Staining of Mouse Testes
Cross-Sections
PFA-fixed paraffin-embedded murine testes cross-sections were
deparaffinized by incubation at 65◦C for 15-20 min until the
paraffin wax had melted, and washed in xylol twice for 10 min.
Next, the sections were rehydrated by a descending ethanol
dilution series (100% (2x), 95%, 90%, 80%, 70%) for 30 sec each
and were kept in distilled water until staining. Cross-sections
were stained in haematoxylin for 3 min and washed in cold
running tap water for 3-5 min. Afterward, the sections were
counterstained with 0.5% eosin for 3 min, removing excess dye
by rinsing in cold running tap water for 1 min. Cross-sections
were then dehydrated in an ascending ethanol dilution series
[70%, 80%, 90%, 95%, 100% (2x)] and cleared in xylol twice for
2 min. Paraffin sections were then mounted with the xylene-
based DPX mounting media for histology (Sigma-Aldrich). H&E
stained sections were stored under the fume hood for 24 h before
imaging by bright-field microscopy using the Zeiss Axio Lab.A1
microscope (Carl Zeiss).
Immunofluorescence Staining of Testes
Cryosections
PFA-fixed murine testis cryosections stored at −20◦C were
defrosted and dried at room temperature for 15 min before their
rehydration by washing in PBS and rinsing in distilled water.
After drying the slides at RT for 10–15 min, cryosections were
blocked (PBS supplemented with 1% BSA, 2% donkey serum
and 0.3% Triton X-100) for 1 h at RT while covered with
parafilm to prevent evaporation. Primary antibodies diluted in
PBST (0.3% Triton X-100/PBS) supplemented with 1% BSA were
added and incubated at 4◦C overnight. On the next day, sections
were washed three times for 5 min with PBST, and fluorescently
conjugated secondary antibodies diluted in PBST supplemented
with 1% BSA were added and incubated in the dark for 1 h at RT.
The sections were then washed three times for 5 min with PBST
and slides were mounted with Fluoromount-G containing DAPI
and photobleaching inhibitors (SouthernBiotech). All steps were
performed in a dark humid chamber to prevent evaporation and
photobleaching. Stained sections were stored at 4◦C for 24 h prior
to imaging by immunofluorescence microscopy. Images were
taken using the Zeiss Observer.Z1 epifluorescence microscope
(Carl Zeiss) and the ZEN 2012 (blue edition) software (Carl
Zeiss). Antibodies used are listed in Supplementary Table 4.
RNA Extraction and qRT-PCR
Quantification
RNA was extracted from cell pellets using the Trizol-containing
reagent peqGold TriFAST according to the manufacturer’s
instructions (PeqLab). RNA pellets were resuspended in RNase-
free water, and DNA digestion was performed prior to RNA
quantification. 0.5–1 µg of RNA was reverse transcribed to
cDNA using the High Capacity cDNA Reverse Transcription
Kit (Applied Biosystems) according to the manufacturer’s
instructions. The cDNA was then diluted 1:5, and a relative
quantification of specific genes was performed in a Bio-Rad
qCycler using either TaqMan probes in iTaq Universal Probes
Supermix or specific primer pairs in iTaq Universal SYBR Green
Supermix (BioRad). Probes and Primers used are listed in
Supplementary Table 3.
Protein Extraction and Western Blotting
Cell pellets were lyzed in RIPA buffer (20 mM Tris–HCl pH
7.5, 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% NP-
40, 1 mM Na3VO4, 1% sodium deoxycholate, 2.5 mM sodium
pyrophosphate, 1 mM glycerophosphate) supplemented with
protease inhibitors and protein lysates were pre-cleared by
centrifugation and quantified using the BCA assay kit (Pierce)
according to the manufacturer’s instructions. Protein lysates were
then denatured by incubation with SDS buffer (12% glycerol,
60 mM Na2EDTA pH 8, 0.6% SDS, 0.003% bromophenol blue)
for 10 min at 95◦C and separated in SDS-PAGE gels in Laemmli
buffer (25 mM Tris, 192 mM glycine, 0.1% SDS). Proteins
were then wet transferred to a nitrocellulose membrane in
transfer buffer (25 mM Tris–HCl pH 7.6, 192 mM glycine, 20%
methanol, 0.03% SDS) and membranes were blocked with 5%
milk powder (w/v) diluted in 1×TBST (50 mM Tris–HCl pH 7.6,
150 mM NaCl, 0.05% Tween-20) prior to overnight incubation
at 4◦C with the required primary antibodies. After washing the
membrane three times with 1 × TBST, they were incubated
with a suitable HRP-coupled secondary antibody for 1 h at RT,
followed by three washing steps with 1 × TBST. Membranes
were developed with the ECL substrate kit (Pierce) according
to the manufacturer’s instructions. Antibodies used are listed in
Supplementary Table 4.
Cell Culture and Transfections
Derivation of wild type murine ESCs (WT, Trim71fl/fl) from
conditional Trim71 full KO mice (Trim71fl/fl; Rosa26-CreERT2)
was previously described (Mitschka et al., 2015). Trim71
knockout murine ESCs (KO, Trim71−/−) were generated from
wild type ESCs by addition of 500 nM of 4-hydroxytamoxifen
in their culture media for 48 h, followed by further culture for
72 h to achieve full protein depletion. ESCs were cultured in
0.1% gelatin-coated dishes and maintained in 2i + LIF DMEM
media (DMEM knockout media supplemented with 15% FCS,
1% penicillin-streptomycin, 0.1 mM NEAA, 2 mM L-GlutaMAX,
100 µM β-mercaptoethanol, 0.2% in-house produced LIF, 1 µM
of MEK/ERK inhibitor PD0325091 and 3 µM of GSK-3
inhibitor CHIR99021).
The human hepatocellular carcinoma cell line HepG2 and
the human embryonic carcinoma cell lines JKT-1, NCCIT,
NTERA-2, TCam-2 and 2102EP were acquired from ATCC.
HepG2, NCCIT and TCam-2 were cultured in RPMI 1640 media
supplemented with 10% FBS and 1% penicillin–streptomycin
antibiotic solution. JKT-1, NTERA -2 and 2012EP cells were
cultured in DMEM media supplemented with 10% FBS and 1%
penicillin-streptomycin antibiotic solution. DNA transfection in
HEK293T cells was conducted with Lipofectamine2000 reagent
following the manufacturer’s instructions and using 1 µg DNA
per µl of Lipofectamine. RNA transfection in TCam-2 cells
was performed with Lipofectamine RNAiMAX reagent following
the manufacturer’s instructions and using 10 pmol siRNA per
2 µL of Lipofectamine. For proliferation assays in TCam-2 cells,
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103 cells per well were seeded, transfected with the siRNAs in
suspension (d0), and cell numbers were monitored over the
course of several days (d1-d6).
In vitro Differentiation of ESCs Into
PGCLCs
Embryonic stem cells growing under naïve pluripotency (d0)
conditions on 0.1% gelatine-coated dishes and 2i + LIF N2B27
media were primed to EpiLCs (resembling post-implantation
EpiSCs) for two days by plating 105 cells per well on 12-well
plates coated with 20 µg/ml fibronectin in priming media (N2B27
media supplemented with 1% penicillin-streptomycin, 2 mM
L-GlutaMAX, 1% KSR, 20 ng/ml Activin A and 12 ng/ml bFGF).
After 24 h (d1), fresh priming media was provided. After 48 h
(d2), EpiLCs were detached with Accutase Stem Cell Pro and
5000 cells per well were plated on a suspension U-bottom 96-
well dish in specification media (GMEM media supplemented
with 15% KSR, 1% penicillin-streptomycin, 0.1 mM NEAA,
2 mM L-GlutaMAX, 100 µM β-mercaptoethanol, 1 mM sodium
pyruvate, 0.2% in-house produced LIF, 50 ng/ml EGF, 100 ng/ml
SCF and 500 ng/ml BMP4). After 6 days in this media
(d8), cells growing as spheroids were recovered, detached by
trypsinization for 10 min at 37◦C and either used for RNA
extraction or double-stained with anti-ITGB3/CD61 and anti-
SSEA-1/CD15 antibodies to determine the number of PGCLCs
by flow cytometry. For staining, trypsinized cells were washed
in 0.1% BSA/PBS, incubated with the antibodies diluted in 0.1%
BSA/PBS for 15 min at 4◦C in the dark and washed again in 0.1%
BSA/PBS. Isotype control antibodies were used to control single
stainings (data not shown). These protocols were adapted from a
previous work (Hayashi et al., 2011). Antibodies used are listed in
Supplementary Table 4.
Analysis of in vivo PGC Migration
E8.5-8.75 embryos were obtained from pregnant females with the
first day of vaginal plug identification defined as 0.5 dpc. Embryos
were dissected in PBS and the upper body was cut off and used for
genotyping. The lower body was dissected to expose the hindgut
and fixed in 4% PFA for 3 h at 4◦C, followed by several washings
in PBS. Embryos were then placed in 70% ethanol at 4◦C for 1 h,
washed once in PBS and stained with Fast Red TR and α-naphthyl
phosphate (Sigma) following the manufacturer’s instructions to
detect alkaline phosphatase-positive cells.
Generation of NCCIT Cells With TRIM71
Frameshift Mutations
Gene editing using the CRISPR/Cas9 system was carried out
using the plasmid pSpCas9(BB)-2A-GFP (PX458), which was a
kind gift from Feng Zhang (Addgene plasmid #48138), after the
insertion of specific sgRNAs targeting TRIM71 RING (sgRNA
1RING 5′-CACCGCTCGCAGACGCTCACGCTGT-3′) or NHL
(sgRNA 1NHL6 5′-CACCGCACAACGATCATTCCGCTGG-
3′) domains. NCCIT cells were transfected with PX458 empty
vector (EV), TRIM71 1RING vector or TRIM71 1NHL6 vector
using Lipofectamine Stem Transfection Reagent (Invitrogen)
following the manufacturer’s instructions. 48 h post- transfection,
transfected (GFP-positive) cells were sorted by FACS and plated
as a bulk population. Growth competition assays (see below)
were performed with sorted bulk populations. Generation of
single clones from the bulk populations was also performed
for subsequent Sanger sequencing, western blot analysis, RNA
extraction and qPCR measurements, and eFluo670 proliferation
assays (see below).
Growth Competition Assays and NGS
Allele Frequency Analysis via Illumina
MiSeq
In order to analyze the growth behavior of CRISPR/Cas9-
edited NCCIT cells, GFP-positive sorted bulk EV-transfected
cells (WT) were mixed 1:1 with either TRIM71 sgRNA 1RING-
transfected cells or TRIM71 sgRNA 1NHL6-transfected cells
(d0) and cultured (2 × 105 cells per well in a 6-well plate) for
three weeks to investigate the population dynamics. Samples
(2 × 105 cells) were taken at d0, d3, d7, d14 and d21 for
genomic DNA extraction. A double PCR strategy was then
applied for the preparation of barcoded amplicons. In a first
PCR reaction, the region around the CRISPR/Cas9-targeted site
was amplified using site-specific forward and reverse primers
with a common 5′ overhang. After PCR product cleaning, a
second PCR was conducted with Illumina index primers which
bind to the common 5′overhangs of the first primers and also
contain unique barcode/index sequences followed by specific 5′
(P5) or 3′ (P7) adaptor sequences. PCR products were then
gel-purified and sequenced on an Illumina MiSeq sequencing
platform via amplification with common primers binding to
P5/P7 adaptor sequences. Data analysis was performed using
CRISPResso2 (Pinello et al., 2016) with the quality cut-off set
at 30 and the minimum identity score for the alignment being
adjusted to 50. After analysis of the sequencing data, single reads
were categorized as wild type, frameshift mutations and in-frame
mutations, and allele frequencies were calculated and displayed as
percentages in a pie chart. Comparing changes in the distribution
of single reads for wild type (EV) and frameshift mutants TRIM71
1RING or TRIM71 1NHL6 over time gives insights into the
dynamics of each cell populations within the initially 1:1 mixed
culture. Allele frequencies of pure wild type (EV) were also
analyzed at d0 and d21 as a control. Analysis of allele frequencies
of pure WT, TRIM71 1RING and TRIM71 1NHL6 populations
before (d0 pure) and after mixing them 1:1 (d0 1:1) ensured that
no PCR product was biased over another based on theoretically
expected versus observed allele frequencies.
eFluor670 Proliferation Assays in NCCIT
Cells
Cells were stained with the proliferation dye eFluor670
(eBiosciences) diluted to 5 µM in PBS (1 ml of PBS per 106 cells)
for 10 min at 37◦C in the dark. The labeling was stopped by
addition of 4-5 volumes of cold FCS and incubation for 5 min
on ice. Cells were washed once with complete growth medium
and once with PBS before seeding them at different densities
per condition in multi-well plates. A fraction of the cells was
used to measure the initial fluorescence intensity (day 0) via
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flow cytometry. The loss of fluorescence intensity overtime was
monitored by flow cytometry for 4 days after staining. Flow
cytometry data was then analyzed with FlowJo. The number
of cell divisions at the end of the experiment was calculated
assuming a decrease of the median fluorescence intensity (MFI)
by half upon each cell division with the following formula:
Division Number = log2 [(MFIday0-MFIunstained)/(MFIday4-
MFIunstained)]. The average cell cycle duration was estimated at
the end of the experiment from the number of cell divisions.
Exome Sequencing Study Population
The study population consisted of 1025 individuals (MERGE
cohort), of whom 908 otherwise healthy men presented with
quantitative spermatogenic impairment. Patients attended the
Centre of Reproductive Medicine and Andrology (CeRA) at
the University Hospital Münster or the Clinic for Urology,
Pediatric Urology and Andrology in Gießen. Neither individuals
with previous chemo-/radiotherapy history nor patients with
Klinefelter syndrome or AZF deletions, which represent known
genetic causes of male infertility, were included in this study.
A subgroup of 247 selected patients was used to investigate novel
genetic causes of the SCO phenotype (SCO subcohort). They
had previously undergone testicular biopsy and presented with
complete and bilateral absence of germ cells. Specifically, two
biopsies were taken from each testis, and tissue sections were
done from each biopsy followed by the evaluation of all tubules
in one random section per biopsy for exact determination of
the phenotype. In addition to this subgroup, 89 male subjects
with complete spermatogenesis also pertaining to the MERGE
cohort were included in the study as controls. All individuals
gave written informed consent and the study protocol has been
approved by the appropriate ethics committees according to the
Declaration of Helsinki (Münster: Kennzeichen 2010-578-f-S,
Gießen: No. 26/11). As further controls, we utilized a Dutch
cohort of 5784 proven fathers sequenced at the Radboudumc
genome diagnostics center in Nijmegen, the Netherlands. These
were healthy fathers of a child with severe developmental delay
and all parents underwent routine exome sequencing for trio
analysis. The fertility of the fathers is expected to be similar to
an unselected sample of the population.
Exome Sequencing Data Generation and
Analysis
In order to perform exome sequencing, genomic DNA
was isolated from the subjects’ peripheral blood applying
standard procedures. Target enrichment, library capture, exome
sequencing and variant calling were performed as previously
described (Wyrwoll et al., 2020). Briefly, DNA was enriched
according to Agilent’s SureSelectQXT Target Enrichment for
Illumina Multiplexed Sequencing Featuring Transposase-Based
Library Prep Technology or Twist Bioscience’s Twist Human
Core Exome protocol. For library capture, SureSelectXT
Human All Exon Kits (Agilent) or Human Core Exome (Twist
Bioscience) were used. Sequencing was then conducted
on Illumina HiScanSQ R©, Illumina NextSeq R©500/550 or
Illumina HiSeqX R© systems.
Exome data analysis was conducted on 247 SCO patients
using our platform Sciobase. We filtered genes based on the
predicted effect of the variant on translated protein (including
only stop-gain, frameshift, and splice donor/acceptor variants)
and the allele frequency in the general population (including
only rare variants (MAF ≤ 0.01) as listed in gnomAD genomic
database (v2.1.11). This first filtering step resulted in the
selection of 3997 genes. We then developed an application
termed Haystack to facilitate the search for previously unknown
causes of genetic diseases, technically applicable to exome
data from patients with any clinical phenotype. In brief,
Haystack aggregates information from multiple databases in
an R Shiny application and allows for filtering based on the
aggregated data, thus minimizing the manual effort required for
candidate gene selection. All source code is publicly available
at GitHub2. We used Haystack to filter variants from our SCO
patients for quality (read depth ≥ 10, variant depth ≥ 4 and
frequency ≥ 40%). The remaining 2870 genes were filtered
again based on genotype and allele frequency in gnomAD
(MAF ≤ 0.01 for homozygous variants and MAF ≤ 0.001 for
heterozygous and X-linked variants) as well as on expression
levels in the testes [including only genes whose expression in
testis was above 50% of its maximum expression across all
tissues according to the GTEx portal (v73)]. Last, genes with
LoF variants present in individuals with intact spermatogenesis
were excluded from the selected 949 genes, leaving a total of
721 genes with LoF variants specifically found in SCO patients.
TRIM71 was found among these genes in a patient with an SCO
phenotype (subject M364). This individual’s DNA was subjected
to Sanger sequencing according to standard procedures in order
to confirm his TRIM71 frameshift variant. PCR was performed
using the primers: F: 5′-TGCAGGCCTAATCGATGCAT-3′; R:
5′-GAAGAAGCTGCGTTGCCCTC-3′.
For the statistical analysis of exome data, the number of
alleles affected and unaffected by LoF variants in TRIM71 in
all gnomAD subjects was compared to affected and unaffected
alleles in the 908 patients with quantitative spermatogenic
impairment (MERGE cohort) and the 247 SCO patients (SCO
subcohort). A two-sided Fisher’s exact test was performed using
the Woolf logit method.
In a subsequent step, exome data of the entire MERGE cohort
and the Dutch father cohort was screened for rare (see MAF
cutoffs above) missense variants in TRIM71 (NM_001039111).
The Z score for TRIM71 was obtained from gnomAD
database. Predicted pathogenicity was assessed using the scoring
algorithms CADD (v14), PolyPhen (v25), SIFT (v26), and
Mutation Taster (v67). All variants identified by our study have
been submitted to ClinVar database (accession ID SUB9045938).








Frontiers in Cell and Developmental Biology | www.frontiersin.org 20 May 2021 | Volume 9 | Article 658966
fcell-09-658966 May 10, 2021 Time: 17:3 # 21
Torres-Fernández et al. TRIM71 in Embryonic Germline Development
aberrations and AZF deletions were excluded in all infertile
patients with LoF or missense variants in TRIM71. Furthermore,
all patients carrying LoF or missense variants in TRIM71 (listed
in Table 1) were evaluated for relevant variants in other genes
(n = 181, Supplementary Table 2) that could explain the
patients’ infertility. The majority of examined genes (n = 170,
Supplementary Table 2A) were taken from a review on the
genetics of male infertility (Oud et al., 2019). The included genes
were selected based on associated phenotypes and had been
rated with limited to definitive clinical evidence. The list was
amended by adding 11 recently published genes (Supplementary
Table 2B). Specifically, the patients’ exome data was screened for
stop-gain, frameshift, and splice acceptor/donor variants as well
as missense variants with a CADD score≥ 20. Only rare variants
(gnomAD MAF ≤ 0.01 for homozygous and MAF ≤ 0.001 for
heterozygous variants) were taken into account. For recessive
genes, variants were only considered if found in homozygous or
likely compound-heterozygous state (two variants in the same
gene in the same patient).
Luciferase Reporter Assays
HEK293T cells were co-transfected with the suitable psiCHECK2
dual luciferase plasmid (Promega) and the specified Flag-tagged
TRIM71 variant construct in a 1:4 ratio. The psiCHECK2
plasmids contained a specific 3′UTR sequence downstream of
the Renilla Luciferase ORF (either the CDKN1A 3′UTR Torres-
Fernández et al., 2019 or an artificial 3′UTR with 8x Let-7 binding
sites Torres-Fernández et al., 2021), while the Firefly Luciferase
encoded in the same plasmid was used as a normalization control.
Transfected cells were harvested 48 h post-transfection and
Renilla and Firefly signals were measured consecutively with the
use of a luminometer (MicroLumat Plus LB96V, Berthold) and
the Dual Luciferase Reporter Assay Kit (Promega) according to
the manufacturer’s instructions.
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